2 Drone Stocks for Your Watchlist

The Iran conflict highlights an asymmetric anti-drone economics: multimillion-dollar missile interceptors are used to stop one-way attack drones costing roughly $20,000–$50,000. The US White House is seeking to triple drone spending to over $75B as part of a larger defense budget request rising from $1T to $1.5T, creating positive momentum for drone/anti-drone tech. Two microcaps are profiled—Applied Energetics (AERG) laser/“directed energy” defense and AgEagle Aerial Systems (UAVS) counter-drone diversification via a 51% JV with ThirdEye Systems and a $10M investment—though both are described as having choppy, budget-timing-linked financial performance.

Analysis

The real economic signal is not “more drones,” but a shift toward layered counter-UAS procurement where the winner is usually the vendor with a credible path to production, integration, and sustainment. That argues for primes and established defense integrators to capture budget dollars first, while microcaps may remain narrative-driven until a program-of-record or repeatable order flow appears. In practice, the first beneficiaries are likely larger platforms and subsystem providers with existing contracting channels, not the smallest pure plays.

For the microcaps, the main risk is that the market front-runs a budget headline while the actual revenue inflection arrives only after months of testing, certification, and procurement delay. AERG’s directed-energy angle has real technical relevance, but weather sensitivity and deployment constraints make it a partial solution; UAVS has a broader business base, yet the counter-drone pivot is still too small to offset dilution and execution risk unless the JV converts into booked orders. The second-order effect is that any sustained demand for anti-drone systems should tighten competition for RF components, optics, and batteries across the defense stack.

Contrarian view: the move may be overdone in the lowest-quality names because legislative language does not equal funded contracts. If the appropriations process slow-walks or the conflict de-escalates, these stocks can give back sharply because they trade more on sentiment than recurring cash flow. The 1-3 month catalyst is committee markup and budget detail; the 6-18 month thesis only works if procurement shifts from one-off demonstrations to repeat production. Falsifiers: no meaningful drone-defense line item, no contract awards, or additional equity raises that dilute per-share upside.

Key Decisions for Investors

• Prefer long RTX or NOC via a 3-6 month horizon over chasing AERG/UAVS: these names are more likely to capture early budget flow and have lower execution risk; use any pullback to add, and cut if defense appropriations omit counter-UAS funding.
• Do not buy AERG outright until there is verifiable contract conversion or a funded program award; treat it as a watchlist name only. Falsifier: no booked revenue inflection by the next 1-2 quarters.
• If expressing the theme speculatively, size UAVS only after monitoring dilution and JV order flow; the setup is better than AERG because there is a broader operating base, but upside is capped if another equity raise is required.
• Use ITA or XAR as the cleaner basket trade for the theme rather than single-name microcaps; the trade works if budget language survives markup and procurement details appear within 1-3 months.
• Avoid shorting the microcaps unless borrow is confirmed and liquidity is sufficient; the better relative-value expression is long established defense exposure, short nothing, until the budget becomes actionable.